The partners can disclose publicly the support provided, including the partners’ identity, the equipment provided, the amount of the Grant and its purpose. If the activity is accredited, the Grantor will comply with all guidelines pertinent to the use of the Accrediting Boards’ names and logos applicable at the time of the communication. OR The Parties undertake to keep confidential the content of this Agreement. Neither Party shall be entitled to disclose any contractual detail to any third party, unless it has obtained the written agreement of the other Party, it is obliged to do so under any applicable law or code of the cooperation between the pharmaceutical industry and healthcare professionals. The confidentiality obligation shall survive the termination of this Agreement. Compliance and objectivity Parties will comply with all relevant laws, rules and regulations, including but not limited to drug law, ethical law applicable in the host country of the event, promotional and competition law and data protection laws. In particular, they will ensure that all legal provisions and the codes on marketing practices (IFPMA, EFPIA, etc.) are respected. The Grantee shall ensure that the content of the Programme complies with and is presented in accordance with best scientific and educational practices. The Grantee certifies that the Grant Activity is independent and free of commercial bias. The Grantor will have neither control nor involvement in the content of the Grant Activity, choice of topic, organising committee members, speakers or participants. In case CME accreditation is sought and obtained for the Grant Activity, the Grantee will comply with all relevant guidelines, rules and regulations set by the Accrediting Bodies. Period of contract The period of contract will last until the end of the Grant Activity on DATE. Reporting The Parties agree that the Grantor will report to the responsible authorities and/or disclose the mandatory details in accordance with mandatory legal requirements or any applicable industry regulations on the cooperation of the pharmaceutical/equipment industry with medical professionals. Governing law and regulation This agreement shall be governed and construed under the laws of COUNTRY. Parties agrees that any dispute arising out or in relation to this agreement, including any question regarding its existence, validity or termination, which cannot be settled amicably between them shall be finally settled under the laws of COUNTRY and conducted in LANGUAGE. Cancelation of contract The Grantor may withdraw from the present contract with the Grantee by giving unilateral written notice to that effect, and the disclosure of the relation will be withdrawn immediately
The partners can disclose publicly the support provided, including the partners’ identity, the equipment provided, the amount of the Grant and its purpose. If the activity is accredited, the Grantor will comply with all guidelines pertinent to the use of the Accrediting Boards’ names and logos applicable at the time of the communication. OR The Parties undertake to keep confidential the content of this Agreement. Neither Party shall be entitled to disclose any contractual detail to any third party, unless it has obtained the written agreement of the other Party, it is obliged to do so under any applicable law or code of the cooperation between the pharmaceutical industry and healthcare professionals. The confidentiality obligation shall survive the termination of this Agreement. Compliance and objectivity Parties will comply with all relevant laws, rules and regulations, including but not limited to drug law, ethical law applicable in the host country of the event, promotional and competition law and data protection laws. In particular, they will ensure that all legal provisions and the codes on marketing practices (IFPMA, EFPIA, etc.) are respected. The Grantee shall ensure that the content of the Programme complies with and is presented in accordance with best scientific and educational practices. The Grantee certifies that the Grant Activity is independent and free of commercial bias. The Grantor will have neither control nor involvement in the content of the Grant Activity, choice of topic, organising committee members, speakers or participants. In case CME accreditation is sought and obtained for the Grant Activity, the Grantee will comply with all relevant guidelines, rules and regulations set by the Accrediting Bodies. Period of contract The period of contract will last until the end of the Grant Activity on DATE. Reporting The Parties agree that the Grantor will report to the responsible authorities and/or disclose the mandatory details in accordance with mandatory legal requirements or any applicable industry regulations on the cooperation of the pharmaceutical/equipment industry with medical professionals. Governing law and regulation This agreement shall be governed and construed under the laws of COUNTRY. Parties agrees that any dispute arising out or in relation to this agreement, including any question regarding its existence, validity or termination, which cannot be settled amicably between them shall be finally settled under the laws of COUNTRY and conducted in LANGUAGE. Cancelation of contract The Grantor may withdraw from the present contract with the Grantee by giving unilateral written notice to that effect, and the disclosure of the relation will be withdrawn immediately